Tango Therapeutics, Inc. short interest in 2025
In 2025, Tango Therapeutics, Inc.'s disclosed short interest ran from 6.53% of shares outstanding on 15 Jan 2025 to 29.70% on 31 Dec 2025, a change of +23.17 percentage points. The year's high was 32.67% on 15 Oct 2025 and its low 5.07% on 31 Jan 2025, averaging 17.57% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 21.63 days on 30 Apr 2025. Full history: Tango Therapeutics, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 6.53% (15 Jan 2025)
- End of year
- 29.70% (31 Dec 2025)
- Change
- +23.17 pp
- High
- 32.67% (15 Oct 2025)
- Low
- 5.07% (31 Jan 2025)
- Average
- 17.57%
- Highest days to cover
- 21.63 (30 Apr 2025)
- SEC filings marked
- 10
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 6.53% | 6.94 | results (8-K) |
| 31 Jan 2025 | 5.07% | 8.82 | |
| 14 Feb 2025 | 5.53% | 9.37 | |
| 28 Feb 2025 | 6.55% | 9.12 | 10-K filed, results (8-K) |
| 14 Mar 2025 | 8.48% | 10.67 | |
| 31 Mar 2025 | 9.35% | 12.46 | |
| 15 Apr 2025 | 10.46% | 16.43 | |
| 30 Apr 2025 | 11.69% | 21.63 | |
| 15 May 2025 | 12.69% | 20.66 | 10-Q filed, results (8-K) |
| 30 May 2025 | 14.72% | 2.51 | |
| 13 Jun 2025 | 14.46% | 3.44 | |
| 30 Jun 2025 | 19.55% | 6.02 | |
| 15 Jul 2025 | 19.86% | 12.84 | |
| 31 Jul 2025 | 20.20% | 13.13 | |
| 15 Aug 2025 | 22.61% | 13.38 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 22.83% | 18.71 | |
| 15 Sep 2025 | 24.09% | 15.98 | |
| 30 Sep 2025 | 30.39% | 10.09 | |
| 15 Oct 2025 | 32.67% | 17.34 | |
| 31 Oct 2025 | 21.84% | 5.33 | results (8-K) |
| 14 Nov 2025 | 22.90% | 10.34 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 24.70% | 9.93 | |
| 15 Dec 2025 | 24.93% | 16.28 | |
| 31 Dec 2025 | 29.70% | 13.49 |
See also: Tango Therapeutics, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.